These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 24018313)

  • 1. [Uncommon adverse effects after interferon therapy in patients with hepatitis C].
    Pisabarros Blanco C; Álvarez Cuenllas B; Gutiérrez Torices C; Linares Torres P; Vivas Alegre S
    Gastroenterol Hepatol; 2013 Dec; 36(10):624-5. PubMed ID: 24018313
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of interferon therapy for aged patients with chronic hepatitis C.
    Arase Y; Kumada H
    J Gastroenterol; 2004 Nov; 39(11):1123-4. PubMed ID: 15580412
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of genetic polymorphisms with interferon-induced haematologic adverse effects in chronic hepatitis C patients.
    Wada M; Marusawa H; Yamada R; Nasu A; Osaki Y; Kudo M; Nabeshima M; Fukuda Y; Chiba T; Matsuda F
    J Viral Hepat; 2009 Jun; 16(6):388-96. PubMed ID: 19200137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interferon treatment of chronic viral hepatitis in Catalonia, Spain. Retrospective analysis].
    Buti M; Bruguera M; Casany S; Gaspar MJ; Esteban R
    Gastroenterol Hepatol; 1999 Mar; 22(3):127-31. PubMed ID: 10228322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon plus Chinese herbs are associated with higher sustained virological response than interferon alone in chronic Hepatitis C: a meta-analysis of randomised trials.
    Zhao S; Liu E; Wei K; Lu S; Chu Y; Li Y; Wang Y; Huang B; Chen Y; Yang P
    Antiviral Res; 2011 Feb; 89(2):156-64. PubMed ID: 21167210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Side effects of interferon therapy for chronic hepatitis C].
    Arase Y
    Nihon Rinsho; 2006 Jul; 64(7):1363-7. PubMed ID: 16838657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-based therapy for dialysis patients with chronic hepatitis C: progress and challenges.
    Liu CH; Liu CJ; Kao JH
    Nephrology (Carlton); 2007 Feb; 12(1):8-10. PubMed ID: 17295654
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple fixed drug eruption with interferon/ribavirin combination therapy for hepatitis C virus infection.
    Sidhu-Malik NK; Kaplan AL
    J Drugs Dermatol; 2003 Oct; 2(5):570-3. PubMed ID: 14558408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy.
    Basso M; Torre F; Picciotto A
    Cancer; 2005 Jun; 103(12):2654-5; author reply 2655. PubMed ID: 15884032
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-term outcomes of interferon therapy for chronic hepatitis].
    Dou XG; Zhao LR
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):10. PubMed ID: 21272451
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of chronic hepatitis C in patients without previous treatment].
    Dehesa Violante M
    Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S42-4. PubMed ID: 12712852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple antiviral therapy as a new option for patients with interferon nonresponsive chronic hepatitis C.
    Brillanti S; Levantesi F; Masi L; Foli M; Bolondi L
    Hepatology; 2000 Sep; 32(3):630-4. PubMed ID: 10960460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene-gene and gene-environment interactions in interferon therapy for chronic hepatitis C.
    Lin E; Hwang Y; Chen EY
    Pharmacogenomics; 2007 Oct; 8(10):1327-35. PubMed ID: 17979507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined effect of an ACE inhibitor, perindopril, and interferon on liver fibrosis markers in patients with chronic hepatitis C.
    Yoshiji H; Noguchi R; Fukui H
    J Gastroenterol; 2005 Feb; 40(2):215-6. PubMed ID: 15770410
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin.
    Nachnani JS; Rao GA; Bulchandani D; Pandya PK; Alba LM
    Ann Hematol; 2010 Feb; 89(2):121-5. PubMed ID: 19565241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in serum lipoprotein profile during interferon therapy in chronic hepatitis C.
    Naeem M; Bacon BR; Mistry B; Britton RS; Di Bisceglie AM
    Am J Gastroenterol; 2001 Aug; 96(8):2468-72. PubMed ID: 11513192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Higher dose of interferon treatment of chronic hepatitis C patient with primary non-response: a case report].
    Liu YL; Chen XY
    Zhonghua Gan Zang Bing Za Zhi; 2010 Dec; 18(12):950. PubMed ID: 21205489
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term outcome after interferon therapy in patients with chronic hepatitis C.
    Buti M; Esteban R
    Ann Hepatol; 2007; 6(4):267-9. PubMed ID: 18007558
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of iron depletion on the response to interferon treatment in patients with chronic hepatitis C. Pilot study].
    Ortiz V; Olaso V; López Viedma B; Córdoba J; Molina JM; Lainez B; Pastor M; Berenguer J
    Gastroenterol Hepatol; 1999 Mar; 22(3):122-6. PubMed ID: 10228321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy.
    Makiyama A; Itoh Y; Kasahara A; Imai Y; Kawata S; Yoshioka K; Tsubouchi H; Kiyosawa K; Kakumu S; Okita K; Hayashi N; Okanoue T
    Cancer; 2004 Oct; 101(7):1616-22. PubMed ID: 15378504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.